glp 1 drugs kidney disease Current GLP-1 receptor agonists and recommendations in patients with Renal effects of GLP-1 receptor

Chen C, Zhang H, Lan Y, et al

BMC, bone mineral content

Clinicians are aware of this and may monitor for gallbladder symptoms if patients lose weight very fast

30.Sinha M Costly Gadgets: Barriers to Market Entry and Price Competition for Generic Drug-Device Combinations in the United States

Bottom line: Oral GLP-1 supplements have a more substantiated evidence base than patches

Supply : In 2025, supply bottlenecks will continue to ease following extensive efforts by Novo Nordisk and Lilly to step up manufacturing, with important implications for competitive dynamics: The large-scale opportunity for compounders will be closing